144 results
8-K
EX-99.1
REPL
Replimune Group Inc
26 Mar 24
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
7:33am
HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed
8-K
EX-99.1
REPL
Replimune Group Inc
8 Feb 24
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
8:05am
, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response.
About RP2
RP2 is a derivative of RP1, Replimune’s lead … -) and GM-CSF to maximize tumor killing potency, the immunogenicity of tumor cell death and the activation of a systemic anti-tumor immune response
8-K
EX-99.1
REPL
Replimune Group Inc
8 Jan 24
Regulation FD Disclosure
8:00am
Immune response Tumor cell death and release of tumor antigens Enhanced T cell priming and activation
©© 2022 Replimune Group Inc. 2023 Replimune Group … -0002 4402-0018 4403-0014 4401-0021 3412-0001 4403-0019 4401-0014 4401-0003 4403-0018 4403-0015 4403-0017 4402-0014 4402-0007 Subjects Death PR SD PD
8-K
EX-99.1
cnglr 9763
5 Dec 23
Other Events
7:19am
8-K
EX-99.1
9v9427b3d
7 Nov 23
Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
8:15am
8-K
EX-99.1
rcwt5zlt0z8 jzz4y
19 Sep 23
Replimune Announces Appointment of Emily Hill as Chief Financial Officer
8:15am
S-3ASR
23d3mxukgb0
3 Aug 23
Automatic shelf registration
8:45am
8-K
EX-99.2
tk5rl rh6
3 Aug 23
Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update
8:09am
8-K
EX-99.1
hlyc7xlv3t4 bu46
3 Aug 23
Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update
8:09am
8-K
EX-99.1
j15abuvv 9q
20 Jul 23
Replimune Announces Sander Slootweg will Depart from its Board of Directors
8:56am